Sprache: Englisch
Verlag: New York, Plenum Publ. Corp., 1989
ISBN 10: 0306432404 ISBN 13: 9780306432408
Anbieter: Antiquariat Thomas Haker GmbH & Co. KG, Berlin, Deutschland
Verbandsmitglied: GIAQ
Hardcover. Zustand: Sehr gut. 272 S. Very good. Shrink wrapped. Sprache: Englisch Gewicht in Gramm: 825.
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 115,17
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
EUR 138,81
Anzahl: 1 verfügbar
In den WarenkorbZustand: Used. pp. 276 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam.
Zustand: Used. pp. 276.
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The chapters of this volume were originally presented at a symposium on 'Depression in Schizophrenics' held at the University of Calgary, Health Sciences Centre on July 06 and 07, 1988. It was the intent of the organizers to draw together leading international researchers to address, in a comprehensive fashion, the persisting problem of depression in schizophrenic individuals. As many of the authors point out, depression was clearly identified as a central problem in schizophrenia by the pioneers of psychiatry. Their wisdom and clinical acumen was lost for a time to be only recently re discovered. Their insights must now be integrated with modern taxonomic systems, evolving etiological models and methods of assessment. With increased recognition of the problem of depression in this population we must also examine appropriate methods of ameliorating the suffering of those afflicted. The conference was divided into sections (theoretical aspects, phenomenology, suicide and treatment) and the chairmen of these sections have given brief introductions. Necessary overlap of topics and methods provided a convergent and validating examination of empirical results which may serve to direct continuing studies. As well we hope that thoughtful review may directly influence clinical practice and thereby improve the quality of life for schizophrenic patients.